Trulieve Cannabis Corp. (TRLV)
NYSE: TRLV · Real-Time Price · USD
9.35
-0.67 (-6.69%)
At close: Nov 19, 2026, 4:00 PM EST
9.48
+0.13 (1.39%)
After-hours: Nov 19, 2026, 4:29 PM EST
Trulieve Cannabis Market Cap
Trulieve Cannabis has a market cap or net worth of $1.8 billion as of November 19, 2026. It is the 6,583rd most valuable company in the world and the 1,754th biggest in the United States.
Market Cap
1.80B
Enterprise Value
2.06B
1-Year Change
n/a
Global Rank
Country Rank
#1,754 United States
Category
ChartMarket Cap Chart
Since June 10, 2026, Trulieve Cannabis's market cap has decreased from $2.21B to $1.80B, a decrease of -18.48%. That is a compound annual growth rate of -37.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.71B | -0.50% |
| Nov 17, 2026 | 1.72B | -2.51% |
| Nov 16, 2026 | 1.76B | -5.23% |
| Nov 13, 2026 | 1.86B | -2.24% |
| Nov 12, 2026 | 1.90B | -0.71% |
| Nov 11, 2026 | 1.92B | 1.26% |
| Nov 10, 2026 | 1.89B | 0.72% |
| Nov 9, 2026 | 1.88B | -4.76% |
| Nov 6, 2026 | 1.97B | 6.05% |
| Nov 5, 2026 | 1.86B | -16.74% |
| Nov 4, 2026 | 2.23B | 0.52% |
| Nov 3, 2026 | 2.22B | 3.96% |
| Nov 2, 2026 | 2.14B | 7.98% |
| Oct 30, 2026 | 1.98B | -3.02% |
| Oct 29, 2026 | 2.04B | -0.19% |
| Oct 28, 2026 | 2.05B | -0.47% |
| Oct 27, 2026 | 2.05B | -1.39% |
| Oct 26, 2026 | 2.08B | 3.84% |
| Oct 23, 2026 | 2.01B | -4.58% |
| Oct 22, 2026 | 2.10B | -0.73% |
| Oct 21, 2026 | 2.12B | 1.94% |
| Oct 20, 2026 | 2.08B | 4.96% |
| Oct 19, 2026 | 1.98B | 2.70% |
| Oct 16, 2026 | 1.93B | -2.81% |
| Oct 15, 2026 | 1.98B | 3.31% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.57B |
| Prestige Consumer Healthcare | 2.29B |
| Regencell Bioscience Holdings | 2.26B |
| Perrigo Company | 2.19B |
| BioCryst Pharmaceuticals | 1.93B |
| Eton Pharmaceuticals | 1.84B |
| Alvotech | 1.56B |
| ANI Pharmaceuticals | 1.48B |